Podiatrists in Decatur, TX Accepting Medicare

5 Podiatrists found. Showing 1 - 5

North Central Texas Podiatry, Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1713 S Fm 51, 103, Decatur, TX 76234 Phone: 940-627-6976    Fax: 940-627-3491

Vincent J Inglima, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 Medical Center Dr, Decatur, TX 76234 Phone: 940-626-2410    Fax: 940-626-2411

Dr. Ricky L. Childers, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1713 S Fm 51, Decatur, TX 76234 Phone: 940-627-6976    Fax: 940-627-3491

Roanoke Foot & Ankle Institute, Pllc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1713 S Fm 51 Ste 103, Decatur, TX 76234 Phone: 940-627-0993

North Central Texas Foot & Ankle, Llc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1713 S Fm 51, Suite 103, Decatur, TX 76234 Phone: 940-627-6976    Fax: 940-627-3491

News Archive

Alkermes commences phase 2 study of ALKS 33 in patients with alcohol dependence

Alkermes, Inc. today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders. The study will assess the safety and efficacy of multiple doses of ALKS 33 in patients with alcohol dependence and is designed to further define the clinical profile of ALKS 33.

Court of Appeals favors Lilly in third-party payor suit

Eli Lilly and Company today announced that the U.S. Court of Appeals for the Second Circuit has agreed with Lilly's position that a class should not have been certified in a pending third-party payor suit, in which unions and insurers who act as third-party payors alleged that they overpaid for Zyprexa prescriptions. The court also agreed with Lilly that plaintiffs' overpricing claims should not go forward.

Media examine reaction to, potential implications of 'functional cure' of infant born with HIV

"The remarkable case of a baby being cured of HIV infection in the United States using readily available drugs has raised new hope for eradicating the infection in infants worldwide, but scientists say it will take a lot more research and much more sensitive diagnostics before this hope becomes a reality," Reuters reports.

Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement

Progenics Pharmaceuticals, Inc. today announced that it has entered into an agreement with Wyeth Pharmaceuticals, a division of Wyeth under which Progenics is regaining all worldwide rights to the RELISTOR® franchise from Wyeth Pharmaceuticals, which Progenics had previously licensed to Wyeth Pharmaceuticals.

Researchers present findings of retrospective analysis of microbicide study at international conference

"More than three years after reporting the primary results of HPTN 035, one of the last trials of the so-called first generation microbicides, researchers from the National Institutes of Health-funded Microbicide Trials Network (MTN) reported two new sets of findings gleaned" from the study data at the International Microbicides Conference in Sydney on Tuesday, an MTN press release states.

Read more Medical News

› Verified 6 days ago